J.P. Marvel Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.62M Sell
37,064
-370
-1% -$56.1K 0.91% 28
2025
Q1
$5.63M Sell
37,434
-170
-0.5% -$25.6K 0.97% 31
2024
Q4
$6.94M Sell
37,604
-1,827
-5% -$337K 1.15% 24
2024
Q3
$7.77M Sell
39,431
-45
-0.1% -$8.86K 1.27% 24
2024
Q2
$8.15M Sell
39,476
-10
-0% -$2.07K 1.34% 21
2024
Q1
$10.7M Buy
39,486
+709
+2% +$192K 1.85% 15
2023
Q4
$9.17M Sell
38,777
-25
-0.1% -$5.91K 1.82% 17
2023
Q3
$7.6M Hold
38,802
1.64% 21
2023
Q2
$8.16M Buy
38,802
+2,380
+7% +$500K 1.7% 19
2023
Q1
$7.35M Buy
36,422
+100
+0.3% +$20.2K 1.66% 22
2022
Q4
$7.91M Hold
36,322
1.86% 23
2022
Q3
$7.15M Sell
36,322
-3
-0% -$590 1.82% 22
2022
Q2
$7.77M Hold
36,325
1.87% 22
2022
Q1
$10.3M Buy
36,325
+507
+1% +$144K 2.1% 20
2021
Q4
$13.5M Buy
35,818
+440
+1% +$166K 2.64% 11
2021
Q3
$14.6M Buy
35,378
+80
+0.2% +$33K 4.4% 6
2021
Q2
$13.1M Buy
35,298
+751
+2% +$278K 2.78% 11
2021
Q1
$10M Buy
34,547
+1,233
+4% +$357K 2.37% 17
2020
Q4
$8.32M Buy
33,314
+104
+0.3% +$26K 2.15% 17
2020
Q3
$7.52M Buy
33,210
+80
+0.2% +$18.1K 2.16% 16
2020
Q2
$5.78M Buy
33,130
+120
+0.4% +$20.9K 1.83% 24
2020
Q1
$4.17M Buy
33,010
+1,390
+4% +$175K 1.58% 27
2019
Q4
$4.83M Hold
31,620
1.4% 35
2019
Q3
$4.19M Buy
+31,620
New +$4.19M 1.34% 33
2019
Q1
$4.22M Buy
29,060
+7,500
+35% +$1.09M 1.37% 33
2018
Q4
$2.44M Buy
+21,560
New +$2.44M 0.88% 40
2018
Q2
$1.76M Hold
15,710
0.54% 52
2018
Q1
$1.68M Hold
15,710
0.52% 54
2017
Q4
$1.72M Hold
15,710
0.52% 54
2017
Q3
$1.7M Sell
15,710
-60
-0.4% -$6.48K 0.54% 53
2017
Q2
$1.6M Sell
15,770
-20
-0.1% -$2.02K 0.53% 51
2017
Q1
$1.42M Sell
15,790
-1,860
-11% -$167K 0.47% 52
2016
Q4
$1.35M Buy
17,650
+3,000
+20% +$229K 0.46% 51
2016
Q3
$1.22M Buy
14,650
+520
+4% +$43.3K 0.43% 51
2016
Q2
$1.17M Buy
+14,130
New +$1.17M 0.41% 52